|
Article Cited by others ORIGINAL ARTICLE
Improved Quality of Life in Patients Treated with Peptide Radionuclides
Traub-Weidinger T, Raderer M, Uffmann M, Angelberger P, Kurtaran A, Leimer M, Preitfellner J, Dudczak R, Virgolini I
Year : 2011| Volume: 10| Issue : 2 | Page no: 115-121 | This article has been cited by | | 1 |
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review |
|
| | Zohreh Maghsoomi,Zahra Emami,Ramin Malboosbaf,Mojtaba Malek,Mohammad E. Khamseh | | | BMC Cancer. 2021; 21(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Peptide receptor radionuclide therapy as a two-step strategy for initially unresectable liver disease from neuroendocrine tumors: a single-center experience |
|
| | Costanza Chiapponi,Nadine Lürssen,Birgit Cremer,Roger Wahba,Uta Drebber,Michael Faust,Matthias Schmidt,Dirk L. Stippel | | | Endocrine. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review |
|
| | D. Magalhães,I. L. Sampaio,G. Ferreira,P. Bogalho,D. Martins-Branco,R. Santos,H. Duarte | | | Journal of Endocrinological Investigation. 2018; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Peptide receptor radionuclide therapy of neuroendocrine tumours |
|
| | Tessa Brabander,Jaap J.M. Teunissen,Casper H.J. Van Eijck,Gaston J.H. Franssen,Richard A. Feelders,Wouter W. de Herder,Dik J. Kwekkeboom | | | Best Practice & Research Clinical Endocrinology & Metabolism. 2015; | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer? |
|
| | Fernanda Vaisman,Paulo Henrique Rosado de Castro,Flavia Paiva Proença Lobo Lopes,Daniel Barretto Kendler,Cencita H.N. Pessoa,Daniel Alves Bulzico,Douglas de Carvalho Leal,Bruno Vilhena,Mario Vaisman,Michel Carneiro,Rossana Corbo | | | Clinical Nuclear Medicine. 2015; 40(2): 123 | | | [Pubmed] [Google Scholar] [DOI] | | | 6 |
A Bridge not too Far: Personalized Medicine with the use of Theragnostic Radiopharmaceuticals |
|
| | Suresh C Srivastava | | | Journal of Postgraduate Medicine, Education and Research. 2013; 47(1): 31 | | | [Pubmed] [Google Scholar] [DOI] | | | 7 |
Paving the Way to Personalized Medicine: Production of Some Promising Theragnostic Radionuclides at Brookhaven National Laboratory |
|
| | Suresh C. Srivastava | | | Seminars in Nuclear Medicine. 2012; 42(3): 151 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
Users Online: 439 
